This study presents a novel machine learning-based prognostic tool for TNBC, offering significant implications for early detection and personalized treatment. The identified gene signature provides a promising approach for improving the management of TNBC, contributing to the advancement of precision oncology.
This study of 2886 veterans showed evidence of heterogeneity and that survival days may be improved for certain patients with mCRPC based on the medication prescribed. Findings suggest that prescription rules based on the patient characteristics, laboratory test results, and comorbidities available to the physician at the time of prescription could improve survival by providing personalized treatment decisions.
The expectations for artificial intelligence (AI) technology have increased considerably in recent years, mainly due to the emergence of deep learning...
These promising results highlight its potential as a key tool in the future development of diagnostic and therapeutic strategies for liver cancers. Lasers Surg. Med. 00:00-00, 2024. 2024 Wiley Periodicals LLC.
У данной статьи нет абстракта.
Cancer is one of the most serious health problems worldwide...
This study could not demonstrate an improvement in the esophageal cancer detection rate using the AI diagnostic support system for ESCC.